Subsequently, we conducted RT-qPCR and WB assays to determine that isocuB could improve the sensitivity of U251 glioma to TMZ by inhibiting hsa-mir-1286a and reduce glioma growth with the modulation of PI3K/AKT and MAPK pathways. This evidence concerns the gene AKT1 and central nervous system cancer.